Evidence map›Paper›PMID 30154711›Full record

ArticleFrontiers in neuroinformatics2018

Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease.

Diego Castillo-Barnes, Javier Ramírez, Fermín Segovia, Francisco J Martínez-Murcia, Diego Salas-Gonzalez, Juan M Górriz

Abstract read
In one paragraph

Article in Frontiers in neuroinformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Detection of parkinson's disease with neuroimaging modalities using machine learning and artificial intelligence: a systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. [Molecular imaging and biology · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Diego Castillo-BarnesSignal Processing and Biomedical Applications (SiPBA), Department of Signal Processing, Networking and Communications, University of Granada, Granada, Spain.
Javier RamírezSignal Processing and Biomedical Applications (SiPBA), Department of Signal Processing, Networking and Communications, University of Granada, Granada, Spain.
Fermín SegoviaSignal Processing and Biomedical Applications (SiPBA), Department of Signal Processing, Networking and Communications, University of Granada, Granada, Spain.
Francisco J Martínez-MurciaSignal Processing and Biomedical Applications (SiPBA), Department of Signal Processing, Networking and Communications, University of Granada, Granada, Spain.
Diego Salas-GonzalezSignal Processing and Biomedical Applications (SiPBA), Department of Signal Processing, Networking and Communications, University of Granada, Granada, Spain.
Juan M GórrizSignal Processing and Biomedical Applications (SiPBA), Department of Signal Processing, Networking and Communications, University of Granada, Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In last years, several approaches to develop an effective Computer-Aided-Diagnosis (CAD) system for Parkinson's Disease (PD) have been proposed. Most of these methods have focused almost exclusively on brain images through the use of Machine-Learning algorithms suitable to characterize structural or functional patterns. Those patterns provide enough information about the status and/or the progression at intermediate and advanced stages of Parkinson's Disease. Nevertheless this information could be insufficient at early stages of the pathology. The Parkinson's Progression Markers Initiative (PPMI) database includes neurological images along with multiple biomedical tests. This information opens up the possibility of comparing different biomarker classification results. As data come from heterogeneous sources, it is expected that we could include some of these biomarkers in order to obtain new information about the pathology. Based on that idea, this work presents an Ensemble Classification model with Performance Weighting. This proposal has been tested comparing Healthy Control subjects (HC) vs. patients with PD (considering both PD and SWEDD labeled subjects as the same class). This model combines several Support-Vector-Machine (SVM) with linear kernel classifiers for different biomedical group of tests-including CerebroSpinal Fluid (CSF), RNA, and Serum tests-and pre-processed neuroimages features (Voxels-As-Features and a list of defined Morphological Features) from PPMI database subjects. The proposed methodology makes use of all data sources and selects the most discriminant features (mainly from neuroimages). Using this performance-weighted ensemble classification model, classification results up to 96% were obtained.

Indexed as

biomarkersensemblemachine learningParkinson's diseasePPMI (Parkinson's progression markers initiative)SPECT (single photon emission computerized tomography)SVM (support-vector-machine)

Identifiers

PMID30154711
PMCPMC6102321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.